Table of Contents
March 01, 2015; Volume 82, Issue 3-
From the Editor
-
Outcome measures need context
Brian F. Mandell, MD, PhD- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 138-139;
- DOI: https://doi.org/10.3949/ccjm.82b.03015
The patient in front of me may differ from those seen in a clinical trial and may care about other outcome measures.
-
-
1-Minute Consult
-
Should we be concerned about thyroid cancer in patients taking glucagon-like peptide 1 receptor agonists?
Subramanian Kannan, MD and Christian Nasr, MD- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 142-144;
- DOI: https://doi.org/10.3949/ccjm.81a.13066
The risk in humans is difficult to quantify, but low.
-
-
Commentary
-
But how many people died? Health outcomes in perspective
Vinay Prasad, MD- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 146-150;
- DOI: https://doi.org/10.3949/ccjm.82a.14058
Before dispensing advice, we should know the effect of what we recommend on all meaningful outcomes.
-
-
The Clinical Picture
-
Pneumatosis cystoides intestinalis: Is surgery always indicated?
Dayakar Kancherla, MD, Swapna Vattikuti, MD and Kishore Vipperla, MD- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 151-152;
- DOI: https://doi.org/10.3949/ccjm.82a.14006
This disease is usually benign, but evidence of necrosis or pneumoperitoneum warrants immediate surgery.
-
-
Smart Testing
-
Does this patient need ultrasonography of the leg to evaluate for deep vein thrombosis?
C. Jessica Dine, MD, MSHPR and Sara L. Wallach, MD- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 153-155;
- DOI: https://doi.org/10.3949/ccjm/82a.14071
If the pretest probability of deep vein thrombosis is low, a normal D-dimer level is enough to rule it out.
-
-
Im Board Review
-
When the dissociation curve shifts to the left
Bhuvnesh Aggarwal, MD, Ruhail Kohli, MD, Rendell Ashton, MD and Moises Auron, MD- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 156-160;
- DOI: https://doi.org/10.3949/ccjm.82a.14044
The patient’s clinical signs and oxygen saturation monitor indicated hypoxemia, but her blood gases were normal.
-
-
Review
-
Is triglyceride therapy worth the effort?
Michael Miller, MD, FACC, FAHA- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 162-166;
- DOI: https://doi.org/10.3949/ccjm.82a.13157
Levels do matter, but no trials of triglyceride-lowering have been done. Weight loss and exercise are encouraged.
-
Left atrial appendage closure: An emerging option in atrial fibrillation when oral anticoagulants are not tolerated
David C. Peritz, MD and Eugene H. Chung, MD, FACC, FHRS, FAHA- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 167-176;
- DOI: https://doi.org/10.3949/ccjm.82a.14117
Can patients undergo a percutaneous procedure to reduce their risk of stroke and avoid lifelong anticoagulation treatment?
-
Managing aneurysmal subarachnoid hemorrhage: It takes a team
Airton Leonardo de Oliveira Manoel, MD, David Turkel-Parrella, MD, Abhijit Duggal, MD, Amanda Murphy, MD, PhD, Victoria McCredie, MD, FRCPC and Thomas R. Marotta, MD, FRCPC- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 177-192;
- DOI: https://doi.org/10.3949/ccjm.82a.14021
There is no silver bullet, but systematic application of small advances maximizes the patient’s chance of recovery.
-
-
Departments
-
Diabetes therapy and cardiac risk (November 2014)
David Bell, MB- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 140;
- DOI: https://doi.org/10.3949/ccjm.82c.03001
A reader comments on diabetes therapy and cardiac risk (November 2013).
-
In Reply: Diabetes therapy and cardiac risk (November 2014)
Robert S. Zimmerman, MD and Kevin M. Pantalone, DO- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 140-141;
- DOI: https://doi.org/10.3949/ccjm.82c.03002
A reader comments on diabetes therapy and cardiac risk (November 2013).
-
Reviewers 2014
- Cleveland Clinic Journal of Medicine March 2015, 82 (3) 161;
-
